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Abstract
Marine secondary metabolites (MSM) from Hypnea musciformis positively affected immune fac-
tors in post larvae of the shrimp, Penaeus monodon. Shrimp were raised in one of three salinity
levels and infected with one of three doses of virulent Vibrio alginolyticus. When challenged with
105 of 106 V. alginolyticus cells/ml, survival was 100% for both control shrimp and shrimp fed a
commercial shrimp feed treated with the MSM extract, regardless of salinity. But, when chal-
lenged with 107 V. alginolyticus cells/ml, survival was 0 in control shrimp at all salinities, and 0,
34%, and 15% in shrimp fed treated feed and raised in 7, 17, and 27 ppt salinity, respectively. 
Introduction
Antibiotic treatment of bacterial, viral, and fun-
gal diseases can cause problems in aquacul-
ture while post infection therapy can pose
environmental dangers (Alabi et al., 1999).
New drugs from seaweeds (macroalgae) have
been successfully used to manage a variety of
diseases (Smit, 2004). Marine secondary
metabolites (MSM) from Ulva fasciata, incor-
porated into shrimp feed, have been studied
as a means of treating diseases in sustainable
shrimp farming (Selvin et al., 2004).
Hypnea musciformis, a red marine
macroalgae, is a highly opportunistic invader,
well known for its large floating blooms in
coastal Maui and other regions in Asia (Smith
et al., 2002). In the present study, we exam-
ined the influence of MSM from H. musci-
formis on the hemogram count (a tool for eval-
uating or indicating immune response) and
survival after Vibrio alginolyticus infection at
different salinities in post larvae of the shrimp,
Penaeus monodon.
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Materials and Methods
Preparation of MSM extract. Hypnea musci-
formis were collected from the Rameswaram
and Mandapam regions (079°20’E, 09°25’N)
on the southeast coast of India, immediately
washed in fresh sea water to remove epi-
phytes, sand, and other extraneous matter,
and air-dried in the shade. Completely dried
material was weighed and finely ground in a
mechanical grinder. Secondary metabolites of
the seaweed were extracted by a bulk extrac-
tion process as described by Selvin and
Lipton (2004). 
Preparation of feed. Commercial pelleted
shrimp feed (no. 4, CP Feeds, Cochin) was
used to prepare top-coated medicated feed.
The crude form of H. musciformis (100%) was
extracted using the solvent, methanol. The
rotary evaporated extract, solvent-free and
viscous, weighs 950 mg/ml. The standard H.
musciformis dose required to cause
immunomodulatory action in P. monodon is
0.950 mg per kg P. monodon (wet wt); in our
laboratory trials, higher concentrations were
found to be toxic. The standard dose was pre-
pared by serially diluting the crude extract in
double distilled water until a concentration of
0.950 mg/ml extract was obtained. One ml of
the diluted extract was sprayed on 500 mg of
pelleted feed using a thin-layer chromatogra-
phy (TLC) sprayer, adding 4.0% gelatin as a
binder. The sprayed medicated feed was
dried in a hot air oven at 40±2°C.
Experimental shrimps. Penaeus monodon
post larvae (stage 20) from the Matsyafed
Shrimp Hatchery in Thirumullavaram, Kerala,
were maintained in three circular 300-l high-
density polymer tanks. The shrimps were
acclimated to one of three salinities (7, 17, or
27 ppt) during a 2-week period. Afterward, 20
shrimp were stocked into each of eighteen 50-
l glass aquaria for the feed experiment. All
treatments were carried out in triplicate.
Experimental shrimp were fed top-coated
medicated feed while control shrimp received
untreated feed, both at the daily rate of 3-4%
of their body weight (Selvin and Lipton, 2004).
The tanks were constantly aerated and 50%
of the water was exchanged daily. Dissolved
oxygen, water temperature, and pH, moni-
tored daily, ranged 4.05-5.3 mg/ml, 27.5-
28.5°C, and 7.2-8.2, respectively. Average
body weight was determined every ten days.
Evaluation of hemogram count. Total and
differential hemogram counts were determined
every 10 days. Hemolymph was withdrawn
from the ventral sinus of each shrimp using a
U-40 1-ml insulin syringe rinsed with the anti-
coagulant trisodium citrate (0.114 M trisodium
citrate, 0.1 M sodium chloride, pH 7.45). The
total hemogram count was estimated using a
hemocytometer with four squares and
expressed as the mean number of cells per ml
hemolymph. The differential hemogram count
indicates the percent of each type of hemocyte
within the hemolymph and was estimated
using a hemolymph smear. The smear was
prepared on a clean glass slide and stained
with Giemsa stain, often used for histopatho-
logical diagnosis of malaria and other para-
sites. Hemocytes were classified as hyaline,
semi granular, or granular (Braak et al., 2002).
Challenge experiment. The bacterial bath
challenge experiment began 30 days after the
beginning of medicated feeding. Vibrio algi-
nolyticus from diseased shrimp were isolated
and identified in our laboratory. The bacteria
was grown for 18-24 h at room temperature
(30-31°C) in a nutrient agar broth supple-
mented with 0.5, 1.0, or 2.0% NaCl to produce
the three test salinities, 7, 17, and 27 ppt,
respectively. Cells were pelletized by centrifu-
gation at 1048 x g for 10 min, suspended in
sterilized water of the respective salinity, and
applied to 500 ml of water in a 1-l beaker to
obtain final bacterial concentrations of 105,
106, and 107 cells/ml. Fifteen shrimp juveniles
were introduced into each bacterial suspen-
sion. Challenge treatments were carried out in
triplicate.
Results
Within a salinity, growth in the treated group
was always higher than in the control (Fig. 1).
In all three salinities, mean total hemogram
count differed between the experimental and
control groups (Fig. 2). The percent hyaline,
semi granular, and granular hemocytes varied
in no certain pattern (Fig 3). Irrespective of
Jean Jose et al.
67Impact of MSM from Hypnea musciformis on Penaeus monodon
Day
Av
g 
bo
dy
 w
t (m
g)
1000
950
900
850
800
750
700
650
600
550
500
450
400
350
300
0 10 20 30
Control (7 ppt)
Experimental (7 ppt)
Control (17 ppt)
Experimental (17 ppt)
Control (27 ppt)
Experimental (27 ppt)
Fig. 1. Growth of Penaeus monodon post larvae fed a commercial
shrimp feed uncoated (control) or coated with an extract of marine sec-
ondary metabolites (MSM) from Hypnea musciformis (experimental).
Fig. 2. Mean total hemocyte count (THC) of hemolymph of Penaeus
monodon post larvae fed a commercial shrimp feed uncoated (control) or
coated with an extract of marine secondary metabolites (MSM) from
Hypnea musciformis (experimental).
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Fig. 3. Differential hemocyte count showing percentage of hyaline,
semi granular, and granular hemocytes in hemolymph of Penaeus mon-
odon post larvae raised at (a) 7 ppt, (b) 17 ppt, or (c) 27 ppt and fed con-
trol or MSM-treated (experimental) shrimp feed.
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salinity, survival was 100% in all control and
treated groups infected with 105 or 106 V.
alginolyticus cells/ml. But when infected at 107
cells/ml, survival was 0 in all control groups
and in the 7 ppt treated group, but 34% in 17
ppt and 15% in 27 ppt treated groups.
Discussion
MSM from macroalgae and its use in aquacul-
ture is an emerging trend of good hope. The
Rhodophyta, Phaeophyta, and Chlorophyta
members of macroalgae contain secondary
metabolites that enhance immunostimulant
activity in shrimps (Felix et al., 2004; Selvin et
al., 2004).
In the present study, there were differ-
ences in total and differential hemogram
counts between the experimental and control
groups in all three salinities. A similar study
revealed that bioactive molecules from
macroalgae enhance the proliferation of
hemocytes in P. monodon (Huxley, 2002). In
P. paulensis, the number of  hemocytes var-
ied 20% between shrimp raised in salinities of
34, 22, or 13 ppt (Moullac and Haffner, 2000).
Enhanced survival of treated shrimp
infected by 107 cells/ml in 17 and 27 ppt
occurred mainly after immune enhancement
resulting from the MSM-incorporated feed.
Feeds that incorporated seaweeds such as U.
fasciata and Sargassum wightii enhanced
measurable immune responses such as total
hemogram count, fluctuation of the differential
hemogram count agglutination titre, phagocyt-
ic rate, bacterial clearance, and proPO cas-
cade system between treated and control
groups (Felix et al., 2004; Selvin et al., 2004).
It is probable that these activities are triggered
by the administration of algal metabolites. In
the present study, comparable immune
responses in the total and differential
hemogram counts were observed.
The present study indicates that incorpo-
rating MSM from H. musciformis in shrimp
feed can act as an immunostimulant in salini-
ties of 17 and 27 ppt. Further research is
needed to understand the immunomodulatory
action of H. musciformis incorporated feed as
a successful package for sustainable shrimp
farming.
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